Skip to main content
Normal View

Medicinal Products Data

Dáil Éireann Debate, Wednesday - 22 February 2017

Wednesday, 22 February 2017

Questions (201)

Michael Healy-Rae

Question:

201. Deputy Michael Healy-Rae asked the Minister for Health his views on a matter (details supplied) with regard to Roaccutane; and if he will make a statement on the matter. [9011/17]

View answer

Written answers

Information held by the Health Products Regulatory Authority (HPRA) on suspected adverse reactions in association with Roaccutane has been forwarded to the Deputy by post.

Top
Share